(9-222) Evaluation of Enoxaparin Given by Subcutaneous (SC) vs. Intravenous (IV) Routes in Achieving Target Anti-Xa Levels in Pediatric Patients

Wednesday, December 7, 2022

8:30 AM – 9:30 AM

Location: Bayside A, Level 1

Category: Research-in-Progress
Topic: Pediatrics

Co-Author(s): Abigail Schauble, Corrie Vasilopoulos, Ahrang Yoo

Primary Author(s)

Catherine Hoang, Pharm.D.
Pharmacy Resident
Presbyterian/St. Luke's Medical Center and The Rocky Mountain Hospital for Children, Colorado